These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6408773)

  • 41. Pharmacological enhancement of recovery in experimental hydronephrosis.
    Yokoyama M; Iwata H; Ochi K; Takeuchi M
    Urol Int; 1985; 40(4):220-3. PubMed ID: 3931321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical relevance of glucocorticoid pharmacodynamics in kidney transplantation: difference between prednisolone and methylprednisolone.
    Hirano T; Oka K; Takeuchi H; Kozaki K; Matsuno N; Nagao T; Kozaki M
    Transplantation; 1997 Sep; 64(5):792-3. PubMed ID: 9311727
    [No Abstract]   [Full Text] [Related]  

  • 43. Improved survival of heart transplants. Graft and/or donor pretreatment with antilymphoblast globulin, cyclophosphamide, or methylprednisolone.
    Toledo-Pereyra LH; Condie RM
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):536-41. PubMed ID: 347179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-induced tolerance to allografts in mice. III. Prolongation of skin graft survival by tolerance induction in congenic mice disparate in the major H-2 antigens.
    Shin T; Himeno K; Mayumi H; Nomoto K
    Transplantation; 1985 Mar; 39(3):333-5. PubMed ID: 3883602
    [No Abstract]   [Full Text] [Related]  

  • 45. Combination drug treatment in immunosuppression. Effect of azathioprine, cyclophosphamide, and methylprednisolone on rabbit renal allografts.
    Friedman EA; Ueno A; Beyr MM; Nicastri AD
    Transplantation; 1973 Jun; 15(6):619-23. PubMed ID: 4577157
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of cyclophosphamide and enhancing serum to suppress renal allograft rejection in the rat.
    Winearls CG; Fabre JW; Millard PR; Morris PJ
    Transplantation; 1979 Oct; 28(4):271-4. PubMed ID: 388758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolongation of rat renal allograft survival by cyclophosphamide and intravenous donor-specific antigens.
    Bramis JP; Schanzer H; Taub RN
    Eur Surg Res; 1977; 9(2):140-54. PubMed ID: 15842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of cyclophosphamide and methylprednisolone on in vitro cellular immune response to allogeneic tumor cells. Correlation with in vivo rejection.
    Gerber M; Andress D; Pioch Y; Radal M; Serrou B
    Transplantation; 1978 Sep; 26(3):142-9. PubMed ID: 309196
    [No Abstract]   [Full Text] [Related]  

  • 49. Detrimental effect of steroids on cyclosporin-A-induced prolonged allograft survival.
    Dunn DC; White DJ; Herbertson BM; Rolles K
    Transplant Proc; 1980 Jun; 12(2):335-8. PubMed ID: 6994303
    [No Abstract]   [Full Text] [Related]  

  • 50. Donor and donor organ pretreatment in cardiac allografts.
    Todd GJ; Nowygrod R; Hardy MA; Reemtsma K
    Surg Forum; 1978; 29():362-4. PubMed ID: 401189
    [No Abstract]   [Full Text] [Related]  

  • 51. Prolongation of rabbit skin allograft survival by donor blood and steroid administered before transplantation.
    King HP; Clunie GJ; Bowes LG; Dumble LJ
    Transplantation; 1982 Nov; 34(5):299-300. PubMed ID: 6760487
    [No Abstract]   [Full Text] [Related]  

  • 52. In vitro alteration of canine renal allografts with cyclophosphamide metabolites.
    Zincke H; Jardine I; Colvin M; Aydin G; Okiye SE
    Transplant Proc; 1983 Jun; 15(2):1698-701. PubMed ID: 6349051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival.
    Langhoff E; Ladefoged J; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thaysen JH
    Lancet; 1986 Jun; 1(8493):1296-7. PubMed ID: 2872430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Donor pretreatment with cyclophosphamide interferes with the enhancing effect of blood transfusion in rats.
    Marquet RL; Heystek GA; van Es AA
    Transplant Proc; 1981 Mar; 13(1 Pt 1):525-7. PubMed ID: 7022887
    [No Abstract]   [Full Text] [Related]  

  • 55. Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin.
    Schmidbauer G; Homeyer A; Bohle RM; Grimm H; Binder J; Kupiec-Weglinski JW
    Transplant Proc; 1997; 29(1-2):607-8. PubMed ID: 9123151
    [No Abstract]   [Full Text] [Related]  

  • 56. Analysis of antiporcine antibodies in cynomolgus recipients of porcine kidneys on cyclophosphamide-based immunosuppression.
    Kunz R; Loss M; Schwinzer R; Rensing S; Kaup J; Klempnauer J; Winkler M
    Transplant Proc; 2000 Aug; 32(5):866. PubMed ID: 10936249
    [No Abstract]   [Full Text] [Related]  

  • 57. Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor.
    Kobayashi T; Taniguchi S; Ye Y; Niekrasz M; Kosanke S; Neethling FA; Wright LJ; Rose AG; White DJ; Cooper DK
    Transplant Proc; 1996 Apr; 28(2):560. PubMed ID: 8623270
    [No Abstract]   [Full Text] [Related]  

  • 58. Orthotopic liver transplantation. Various immunosuppressive regimens to improve survival.
    Toledo-Pereyra LH; Bandlien KO; MacKenzie GH; Gordon DA
    Am Surg; 1984 May; 50(5):258-63. PubMed ID: 6372562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent state of cyclophosphamide-induced skin allograft tolerance in mice.
    Fontalin LN; Chernyakhovskaya IYu
    Immunobiology; 1991 Jun; 182(3-4):323-33. PubMed ID: 1916879
    [No Abstract]   [Full Text] [Related]  

  • 60. Prolongation of kidney allograft survival in dogs with donor pretreatment.
    Chassot PG; Beaudoin JG; Guttmann RD
    Surg Forum; 1974; 25(0):314-6. PubMed ID: 4612787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.